Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program
- PMID: 22095547
- PMCID: PMC3297096
- DOI: 10.1164/rccm.201107-1317PP
Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program
Abstract
The National Heart, Lung, and Blood Institute Severe Asthma Research Program (SARP) has characterized over the past 10 years 1,644 patients with asthma, including 583 individuals with severe asthma. SARP collaboration has led to a rapid recruitment of subjects and efficient sharing of samples among participating sites to conduct independent mechanistic investigations of severe asthma. Enrolled SARP subjects underwent detailed clinical, physiologic, genomic, and radiological evaluations. In addition, SARP investigators developed safe procedures for bronchoscopy in participants with asthma, including those with severe disease. SARP studies revealed that severe asthma is a heterogeneous disease with varying molecular, biochemical, and cellular inflammatory features and unique structure-function abnormalities. Priorities for future studies include recruitment of a larger number of subjects with severe asthma, including children, to allow further characterization of anatomic, physiologic, biochemical, and genetic factors related to severe disease in a longitudinal assessment to identify factors that modulate the natural history of severe asthma and provide mechanistic rationale for management strategies.
Figures



References
-
- Busse WW, Banks-Schlegel S, Wenzel SE. Pathophysiology of severe asthma. J Allergy Clin Immunol 2000;106:1033–1042 - PubMed
-
- Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000;162:2341–2351 - PubMed
-
- The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003;22:470–477 - PubMed
-
- Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol 1991;88:425–534 - PubMed
-
- Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007;119:405–413 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL091762/HL/NHLBI NIH HHS/United States
- HL69170/HL/NHLBI NIH HHS/United States
- HL69349/HL/NHLBI NIH HHS/United States
- UL1 RR025011/RR/NCRR NIH HHS/United States
- 1UL1RR024992/RR/NCRR NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- 1UL1RR025011/RR/NCRR NIH HHS/United States
- R01 HL069130/HL/NHLBI NIH HHS/United States
- M01 RR03186/RR/NCRR NIH HHS/United States
- HL69130/HL/NHLBI NIH HHS/United States
- R01 HL069167/HL/NHLBI NIH HHS/United States
- HL69174/HL/NHLBI NIH HHS/United States
- UL1 RR024989/RR/NCRR NIH HHS/United States
- R01 HL091762/HL/NHLBI NIH HHS/United States
- R01 HL069155/HL/NHLBI NIH HHS/United States
- HL69116/HL/NHLBI NIH HHS/United States
- R01 HL069174/HL/NHLBI NIH HHS/United States
- M01 RR003186/RR/NCRR NIH HHS/United States
- G1000758/MRC_/Medical Research Council/United Kingdom
- R01 HL069116/HL/NHLBI NIH HHS/United States
- 1UL1RR024989/RR/NCRR NIH HHS/United States
- M01 RR007122-14/RR/NCRR NIH HHS/United States
- R01 HL069170/HL/NHLBI NIH HHS/United States
- R01 HL069349/HL/NHLBI NIH HHS/United States
- UL1 RR024992/RR/NCRR NIH HHS/United States
- HL69167/HL/NHLBI NIH HHS/United States
- HL69155/HL/NHLBI NIH HHS/United States
- U10 HL109164/HL/NHLBI NIH HHS/United States
- M01 RR007122/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous